Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Entourage Effect and Analytical Chemistry: Chromatography as a Tool in the Analysis of the Secondary Metabolism of Cannabis sativa L.

Author(s): Fresia Melina Silva Sofrás and Martin Federico Desimone*

Volume 29, Issue 6, 2023

Published on: 14 November, 2022

Page: [394 - 406] Pages: 13

DOI: 10.2174/1381612829666221103093542

Price: $65

Abstract

Cannabis sativa L. has been used as medicine for thousands of years. Since the early identification of tetrahydrocannabinol (THC) in 1960, pharmacological activities were attributed to a group of unique structures named cannabinoids. For decades, research and development were applied to determine different cannabinoids and their medicinal properties. Nowadays there is evidence that the therapeutic benefits of the plant are based on the synergy of cannabinoids and other secondary metabolites such as terpenes and flavonoids. Differences between the medical performance of isolated compounds like cannabidiol (CBD) or THC and full-spectrum plant extracts are notable. Indeed, the superiority of the last one is provoked by the synergy between various different compounds. This improved medicinal effect is called the entourage effect. Chromatography has become the method of choice for the determination of cannabinoids, terpenes, and flavonoids, so it represents an excellent tool for a proper characterization of the plant and plant derived products. The objective of characterization relies not only in analyzing the fingerprint of cannabis, but also to identify different chemotypes for medical purposes. To understand the contributions of each natural product to this “entourage effect”, this review presents an in-depth analysis of the utilization of High-performance liquid chromatography (HPLC), Gas chromatography (GC) and other methods for the analysis of phytocomponents of Cannabis sativa L. In this sense, a representative number of examples and advances made in the field together with limitations and future needs are provided. It can be concluded that standardized protocols and quality control policies and procedures are necessary for the comprehensive analysis of cannabis extracts and derivatives.

Keywords: Entourage effect, synergy, inflorescences, cannabis, medicinal plant, trichomes, cannabinoids, chemotypes, chromatography.

« Previous Next »
[1]
Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr 2006; 28(2): 153-7.
[http://dx.doi.org/10.1590/S1516-44462006000200015] [PMID: 16810401]
[2]
Kalant H. Medicinal use of cannabis: History and current status. Pain Res Manag 2001; 6(2): 80-91.
[http://dx.doi.org/10.1155/2001/469629] [PMID: 11854770]
[3]
Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 2007; 4(8): 1614-48.
[http://dx.doi.org/10.1002/cbdv.200790144] [PMID: 17712811]
[4]
Chandra S, Lata H, ElSohly MA. Cannabis sativa L. - Botany and Biotechnology. Springer Cham 2017.
[5]
Tanney CAS, Backer R, Geitmann A, Smith DL. Cannabis glandular trichomes: A cellular metabolite factory. Front Plant Sci 2021; 12: 721986.
[http://dx.doi.org/10.3389/fpls.2021.721986] [PMID: 34616415]
[6]
Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013; 64(1): 21-47.
[http://dx.doi.org/10.1146/annurev-psych-113011-143739] [PMID: 22804774]
[7]
Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics 2015; 12(4): 692-8.
[http://dx.doi.org/10.1007/s13311-015-0374-6] [PMID: 26271952]
[8]
Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F. The medicinal use of cannabis and cannabinoids an international cross-sectional survey on administration forms. J Psychoactive Drugs 2013; 45(3): 199-210.
[http://dx.doi.org/10.1080/02791072.2013.805976] [PMID: 24175484]
[9]
Kowal MA, Hazekamp A, Grotenhermen F. Review on clinical studies with cannabis and cannabinoids 2010-2014. Cannabinoids 2016; 11: 1-18.
[10]
Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 2006; 105(1-2): 1-25.
[http://dx.doi.org/10.1016/j.jep.2006.02.001] [PMID: 16540272]
[11]
Gaoni Y, Mechoulam R, Gaoni Y, Mechoulam R. Isolation and structure of DELTA.+- tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 1971; 93(1): 217-24.
[http://dx.doi.org/10.1021/ja00730a036] [PMID: 5538858]
[12]
Devinsky O, Patel AD, Cross JH, et al. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome. N Engl J Med 2018; 378(20): 1888-97.
[http://dx.doi.org/10.1056/NEJMoa1714631] [PMID: 29768152]
[13]
Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: A unified critical inventory. Nat Prod Rep 2016; 33(12): 1357-92.
[http://dx.doi.org/10.1039/C6NP00074F] [PMID: 27722705]
[14]
MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med 2018; 49: 12-9.
[http://dx.doi.org/10.1016/j.ejim.2018.01.004] [PMID: 29307505]
[15]
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front Plant Sci 2016; 7: 19.
[http://dx.doi.org/10.3389/fpls.2016.00019] [PMID: 26870049]
[16]
AL Ubeed HMS, Bhuyan DJ, Alsherbiny MA, Basu A, Vuong QV. A comprehensive review on the techniques for extraction of bioactive compounds from medicinal cannabis. Molecules 2022; 27(3): 604.
[http://dx.doi.org/10.3390/molecules27030604] [PMID: 35163863]
[17]
Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: No “Strain,” no gain. Front Plant Sci 2019; 9: 1969.
[http://dx.doi.org/10.3389/fpls.2018.01969] [PMID: 30687364]
[18]
Koltai H, Namdar D. Cannabis Phytomolecule ‘Entourage’: From domestication to medical use. Trends Plant Sci 2020; 25(10): 976-84.
[http://dx.doi.org/10.1016/j.tplants.2020.04.007] [PMID: 32417167]
[19]
Jin D, Jin S, Yu Y, Lee C, Chen J. Classification of cannabis cultivars marketed in Canada for medical purposes by quantification of cannabinoids and terpenes using HPLC-DAD and GC-MS. J Anal Bioanal Tech 2017; 8(1): 349.
[http://dx.doi.org/10.4172/2155-9872.1000349]
[20]
Hazekamp A, Tejkalová K, Papadimitriou S. Cannabis: From cultivar to chemovar II—A metabolomics approach to cannabis classification. Cannabis Cannabinoid Res 2016; 1(1): 202-15.
[http://dx.doi.org/10.1089/can.2016.0017]
[21]
Citti C, Braghiroli D, Vandelli MA, Cannazza G. Pharmaceutical and biomedical analysis of cannabinoids: A critical review. J Pharm Biomed Anal 2018; 147: 565-79.
[http://dx.doi.org/10.1016/j.jpba.2017.06.003] [PMID: 28641906]
[22]
Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: An update on current evidence and cannabis science. Headache 2018; 58(7): 1139-86.
[http://dx.doi.org/10.1111/head.13345] [PMID: 30152161]
[23]
Deidda R, Dispas A, De Bleye C, Hubert P, Ziemons É. Critical review on recent trends in cannabinoid determination on cannabis herbal samples: From chromatographic to vibrational spectroscopic techniques. Anal Chim Acta 2022; 1209: 339184.
[http://dx.doi.org/10.1016/j.aca.2021.339184] [PMID: 35569861]
[24]
Borille BT, González M, Steffens L, Ortiz RS, Limberger RP. Cannabis sativa: A systematic review of plant analysis. Drug Analytical Research 2017; 1(1): 1-23.
[http://dx.doi.org/10.22456/2527-2616.73676]
[25]
Potvin S, Amar MB. Review: Cannabis use increases the risk of psychotic outcomes. Evid Based Ment Health 2008; 11(1): 28.
[http://dx.doi.org/10.1136/ebmh.11.1.28] [PMID: 18223063]
[26]
Radwan MM, Chandra S, Gul S, ElSohly MA. Cannabinoids, phenolics, terpenes and alkaloids of cannabis. Molecules 2021; 26(9): 2774.
[http://dx.doi.org/10.3390/molecules26092774] [PMID: 34066753]
[27]
Citti C, Linciano P, Russo F, et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol. Sci Rep 2019; 9(1): 20335.
[http://dx.doi.org/10.1038/s41598-019-56785-1] [PMID: 31889124]
[28]
Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56(11): 317-33.
[http://dx.doi.org/10.1111/j.1753-4887.1998.tb01670.x] [PMID: 9838798]
[29]
Robbins RJ. Phenolic acids in foods: An overview of analytical methodology. J Agric Food Chem 2003; 51(10): 2866-87.
[http://dx.doi.org/10.1021/jf026182t] [PMID: 12720366]
[30]
Pavarini DP, Pavarini SP, Niehues M, Lopes NP. Exogenous influences on plant secondary metabolite levels. Anim Feed Sci Technol 2012; 176(1-4): 5-16.
[http://dx.doi.org/10.1016/j.anifeedsci.2012.07.002]
[31]
Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: An overview. Medicines 2018; 5(3): 93.
[http://dx.doi.org/10.3390/medicines5030093] [PMID: 30149600]
[32]
Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in cannabis. Phytochem Rev 2008; 7(3): 615-39.
[http://dx.doi.org/10.1007/s11101-008-9094-4]
[33]
Koltai H, Shalev N. Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular mechanisms and potential in the fight against ovarian cancer and stem cells. Cancers 2022; 14(17): 4299.
[http://dx.doi.org/10.3390/cancers14174299] [PMID: 36077833]
[34]
Erridge S, Mangal N, Salazar O, Pacchetti B, Sodergren MH. Cannflavins - From plant to patient: A scoping review. Fitoterapia 2020; 146: 104712.
[http://dx.doi.org/10.1016/j.fitote.2020.104712] [PMID: 32858172]
[35]
Eggers C, Fujitani M, Kato R, Smid S. Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid β-mediated neurotoxicity in PC12 cells: Comparison with geranylated flavonoids, mimulone and diplacone. Biochem Pharmacol 2019; 169: 113609.
[http://dx.doi.org/10.1016/j.bcp.2019.08.011] [PMID: 31437460]
[36]
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011; 163(7): 1344-64.
[http://dx.doi.org/10.1111/j.1476-5381.2011.01238.x] [PMID: 21749363]
[37]
Calvi L, Pentimalli D, Panseri S, et al. Comprehensive quality evaluation of medical Cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC-MS and LC-HRMS (q-exactive orbitrap®) approach. J Pharm Biomed Anal 2018; 150: 208-19.
[http://dx.doi.org/10.1016/j.jpba.2017.11.073] [PMID: 29247961]
[38]
Livingston SJ, Quilichini TD, Booth JK, et al. Cannabis glandular trichomes alter morphology and metabolite content during flower maturation. Plant J 2020; 101(1): 37-56.
[http://dx.doi.org/10.1111/tpj.14516] [PMID: 31469934]
[39]
Hillig KW. A chemotaxonomic analysis of terpenoid variation in Cannabis. Biochem Syst Ecol 2004; 32(10): 875-91.
[http://dx.doi.org/10.1016/j.bse.2004.04.004]
[40]
McPartland JM, Russo EB. Cannabis and Cannabis extracts: Greater than the sum of their parts? J Cannabis Ther 2001; 1(3-4): 103-32.
[http://dx.doi.org/10.1300/J175v01n03_08]
[41]
Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, et al. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 1998; 353(1): 23-31.
[42]
Mechoulam R, Ben-Shabat S. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: The ongoing story of cannabis. Nat Prod Rep 1999; 16(2): 131-43.
[http://dx.doi.org/10.1039/a703973e] [PMID: 10331283]
[43]
Bonn-Miller MO, ElSohly MA, Loflin MJE, Chandra S, Vandrey R. Cannabis and cannabinoid drug development: Evaluating botanical versus single molecule approaches. Int Rev Psychiatry 2018; 30(3): 277-84.
[http://dx.doi.org/10.1080/09540261.2018.1474730] [PMID: 30179534]
[44]
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 2013; 46(2): 207-18.
[http://dx.doi.org/10.1016/j.jpainsymman.2012.07.014] [PMID: 23141881]
[45]
Gallily R, Yekhtin Z, Hanuš LO. Overcoming the bell-shaped dose-response of cannabidiol by using Cannabis extract enriched in cannabidiol. Pharmacol Pharm 2015; 6(2): 75-85.
[http://dx.doi.org/10.4236/pp.2015.62010]
[46]
Velasco G, Sánchez C, Guzmán M. Anticancer mechanisms of cannabinoids. Curr Oncol 2016; 23(11): 23-32.
[http://dx.doi.org/10.3747/co.23.3080] [PMID: 27022311]
[47]
Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, et al. Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol 2018; 157: 285-93.
[http://dx.doi.org/10.1016/j.bcp.2018.06.025] [PMID: 29940172]
[48]
Namdar D, Voet H, Ajjampura V, et al. Terpenoids and phytocannabinoids co-produced in Cannabis sativa strains show specific interaction for ell cytotoxic activity. Molecules 2019; 24(17): 3031.
[http://dx.doi.org/10.3390/molecules24173031] [PMID: 31438532]
[49]
LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep 2021; 11(1): 8232.
[http://dx.doi.org/10.1038/s41598-021-87740-8] [PMID: 33859287]
[50]
LaVigne J, Hecksel R, Streicher JM. In defense of the “Entourage Effect”: Terpenes found in Cannabis sativa activate the cannabinoid receptor 1 in vivo. FASEB J 2020; 34(S1): 1.
[http://dx.doi.org/10.1096/fasebj.2020.34.s1.04020]
[51]
Heblinski M, Santiago M, Fletcher C, et al. Terpenoids Commonly Found in Cannabis sativa do not modulate the actions of phytocannabinoids or endocannabinoids on TRPA1 and TRPV1 channels. Cannabis Cannabinoid Res 2020; 5(4): 305-17.
[http://dx.doi.org/10.1089/can.2019.0099] [PMID: 33376801]
[52]
Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M. Absence of Entourage: Terpenoids commonly found in cannabis sativa do not modulate the functional activity of Δ9-THC at Human CB1 and CB2 receptors. Cannabis Cannabinoid Res 2019; 4(3): 165-76.
[http://dx.doi.org/10.1089/can.2019.0016] [PMID: 31559333]
[53]
Nuutinen T. Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus. Eur J Med Chem 2018; 157: 198-228.
[http://dx.doi.org/10.1016/j.ejmech.2018.07.076] [PMID: 30096653]
[54]
Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). Am J Bot 2004; 91(6): 966-75.
[http://dx.doi.org/10.3732/ajb.91.6.966] [PMID: 21653452]
[55]
Sommano SR, Chittasupho C, Ruksiriwanich W, Jantrawut P. The Cannabis terpenes. Molecules 2020; 25(24): 5792.
[http://dx.doi.org/10.3390/molecules25245792] [PMID: 33302574]
[56]
Hanuš LO, Hod Y. Terpenes/terpenoids in cannabis: Are they important? Med Cannabis Cannabinoids 2020; 3(1): 25-60.
[http://dx.doi.org/10.1159/000509733] [PMID: 34676339]
[57]
Birenboim M, Chalupowicz D, Maurer D, et al. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles. Phytochemistry 2022; 200: 113215.
[http://dx.doi.org/10.1016/j.phytochem.2022.113215] [PMID: 35483556]
[58]
Leghissa A, Hildenbrand ZL, Schug KA. A review of methods for the chemical characterization of cannabis natural products. J Sep Sci 2018; 41(1): 398-415.
[http://dx.doi.org/10.1002/jssc.201701003] [PMID: 28986974]
[59]
Micalizzi G, Vento F, Alibrando F, Donnarumma D, Dugo P, Mondello L. Cannabis sativa L.: A comprehensive review on the analytical methodologies for cannabinoids and terpenes characterization. J Chromatogr A 2021; 1637(25): 461864.
[http://dx.doi.org/10.1016/j.chroma.2020.461864] [PMID: 33422797]
[60]
De Backer B, Debrus B, Lebrun P, et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877(32): 4115-24.
[http://dx.doi.org/10.1016/j.jchromb.2009.11.004] [PMID: 19932642]
[61]
Giese MW, Lewis MA, Giese L, Smith KM. Development and validation of a reliable and robust method for the analysis of cannabinoids and terpenes in cannabis. J AOAC Int 2015; 98(6): 1503-22.
[http://dx.doi.org/10.5740/jaoacint.15-116] [PMID: 26651562]
[62]
Peschel W, Politi M. 1 H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. Talanta 2015; 140: 150-65.
[http://dx.doi.org/10.1016/j.talanta.2015.02.040] [PMID: 26048837]
[63]
Swift W, Wong A, Li KM, Arnold JC, McGregor IS. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS One 2013; 8(7): e70052.
[http://dx.doi.org/10.1371/journal.pone.0070052] [PMID: 23894589]
[64]
Križman M. A simplified approach for isocratic HPLC analysis of cannabinoids by fine tuning chromatographic selectivity. Eur Food Res Technol 2020; 246(2): 315-22.
[http://dx.doi.org/10.1007/s00217-019-03344-7]
[65]
Mazzara E, Torresi J, Fico G, et al. A comprehensive phytochemical analysis of terpenes, polyphenols and cannabinoids, and micro-morphological characterization of 9 commercial varieties of cannabis sativa L. Plants 2022; 11(7): 891.
[http://dx.doi.org/10.3390/plants11070891] [PMID: 35406871]
[66]
Ciolino LA, Ranieri TL, Taylor AM. Commercial cannabis consumer products part 2: HPLC-DAD quantitative analysis of cannabis cannabinoids. Forensic Sci Int 2018; 289: 438-47.
[http://dx.doi.org/10.1016/j.forsciint.2018.05.033] [PMID: 30025568]
[67]
Mandrioli M, Tura M, Scotti S, Gallina Toschi T. Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in Cannabis sativa L. Molecules 2019; 24(11): 2113.
[http://dx.doi.org/10.3390/molecules24112113] [PMID: 31167395]
[68]
Gul W, Gul SW, Radwan MM, et al. Determination of 11 Cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. J AOAC Int 2015; 98(6): 1523-8.
[http://dx.doi.org/10.5740/jaoacint.15-095] [PMID: 26651563]
[69]
Zivovinovic S, Alder R, Allenspach MD, Steuer C. Determination of cannabinoids in Cannabis sativa L. samples for recreational, medical, and forensic purposes by reversed-phase liquid chromatography-ultraviolet detection. J Anal Sci Technol 2018; 9(1): 27.
[http://dx.doi.org/10.1186/s40543-018-0159-8]
[70]
Brighenti V, Pellati F, Steinbach M, Maran D, Benvenuti S. Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp). J Pharm Biomed Anal 2017; 143: 228-36.
[http://dx.doi.org/10.1016/j.jpba.2017.05.049] [PMID: 28609672]
[71]
Pacifici R, Marchei E, Salvatore F, Guandalini L, Busardò FP, Pichini S. Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry. Clin Chem Laboratory Med (CCLM) 2017; 55(10): 1555-63.
[http://dx.doi.org/10.1515/cclm-2016-1060] [PMID: 28207408]
[72]
Citti C, Ciccarella G, Braghiroli D, Parenti C, Vandelli MA, Cannazza G. Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J Pharm Biomed Anal 2016; 128: 201-9.
[http://dx.doi.org/10.1016/j.jpba.2016.05.033] [PMID: 27268223]
[73]
Namdar D, Mazuz M, Ion A, Koltai H. Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods. Ind Crops Prod 2018; 113: 376-82.
[http://dx.doi.org/10.1016/j.indcrop.2018.01.060]
[74]
Ternelli M, Brighenti V, Anceschi L, et al. Innovative methods for the preparation of medical Cannabis oils with a high content of both cannabinoids and terpenes. J Pharm Biomed Anal 2020; 186: 113296.
[http://dx.doi.org/10.1016/j.jpba.2020.113296] [PMID: 32334134]
[75]
Ambach L, Penitschka F, Broillet A, König S, Weinmann W, Bernhard W. Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. Forensic Sci Int 2014; 243: 107-11.
[http://dx.doi.org/10.1016/j.forsciint.2014.06.008] [PMID: 25005819]
[76]
Taschwer M, Schmid MG. Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria-impact of different storage temperatures on stability. Forensic Sci Int 2015; 254: 167-71.
[http://dx.doi.org/10.1016/j.forsciint.2015.07.019] [PMID: 26247127]
[77]
Gambaro V, Dell’Acqua L, Farè F, Froldi R, Saligari E, Tassoni G. Determination of primary active constituents in Cannabis preparations by high-resolution gas chromatography/flame ionization detection and high-performance liquid chromatography/UV detection. Anal Chim Acta 2002; 468(2): 245-54.
[http://dx.doi.org/10.1016/S0003-2670(02)00660-8]
[78]
Dei Cas M, Arnoldi S, Monguzzi L, et al. Characterization of chemotype-dependent terpenoids profile in cannabis by headspace gas-chromatography coupled to time-of-flight mass spectrometry. J Pharm Biomed Anal 2021; 203: 114180.
[http://dx.doi.org/10.1016/j.jpba.2021.114180] [PMID: 34111731]
[79]
Hazekamp A, Peltenburg A, Verpoorte R, Giroud C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. J Liq Chromatogr Relat Technol 2005; 28(15): 2361-82.
[http://dx.doi.org/10.1080/10826070500187558]
[80]
Delgado-Povedano MM, Sánchez-Carnerero Callado C, Priego-Capote F, Ferreiro-Vera C. Untargeted characterization of extracts from Cannabis sativa L. cultivars by gas and liquid chromatography coupled to mass spectrometry in high resolution mode. Talanta 2020; 208: 120384.
[http://dx.doi.org/10.1016/j.talanta.2019.120384] [PMID: 31816756]
[81]
Citti C, Pacchetti B, Vandelli MA, Forni F, Cannazza G. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J Pharm Biomed Anal 2018; 149: 532-40.
[http://dx.doi.org/10.1016/j.jpba.2017.11.044] [PMID: 29182999]
[82]
Ibrahim E, Gul W, Gul S, et al. Determination of acid and neutral cannabinoids in extracts of different strains of cannabis sativa using GC-FID. Planta Med 2018; 84(4): 250-9.
[http://dx.doi.org/10.1055/s-0043-124088] [PMID: 29237190]
[83]
Casiraghi A, Roda G, Casagni E, et al. Extraction method and analysis of cannabinoids in cannabis olive oil preparations. Planta Med 2018; 84(4): 242-9.
[http://dx.doi.org/10.1055/s-0043-123074] [PMID: 29202510]
[84]
Ciolino LA, Ranieri TL, Taylor AM. Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids. Forensic Sci Int 2018; 289: 429-37.
[http://dx.doi.org/10.1016/j.forsciint.2018.05.032] [PMID: 29954632]
[85]
Ibrahim E, Hadad G, Abdel Salam R, et al. Recent analytical approaches in quality control of Cannabis sativa L. and its preparations. Records Pharm Biomed Sci 2018; 2(2): 10-22.
[http://dx.doi.org/10.21608/rpbs.2018.5518.1014]
[86]
Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 2010; 71(17-18): 2058-73.
[http://dx.doi.org/10.1016/j.phytochem.2010.10.001] [PMID: 21040939]
[87]
Tipparat P, Natakankitkul S, Chamnivikaipong P, Chutiwat S. Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application. Forensic Sci Int 2012; 215(1-3): 164-70.
[http://dx.doi.org/10.1016/j.forsciint.2011.05.006] [PMID: 21636228]
[88]
Slosse A, Van Durme F, Samyn N, Mangelings D, Vander Heyden Y. Evaluation of data preprocessings for the comparison of GC-MS chemical profiles of seized cannabis samples. Forensic Sci Int 2020; 310: 110228.
[http://dx.doi.org/10.1016/j.forsciint.2020.110228] [PMID: 32169669]
[89]
Stefkov G, Cvetkovikj Karanfilova I, Stoilkovska Gjorgievska V, et al. Analytical techniques for phytocannabinoid profiling of cannabis and cannabis-based products—a comprehensive review. Molecules 2022; 27(3): 975.
[http://dx.doi.org/10.3390/molecules27030975] [PMID: 35164240]
[90]
Mechoulam R, Ben-Zvi Z, Gaoni Y. Hashish--13. On the nature of the Beam test. Tetrahedron 1968; 24(16): 5615-24.
[http://dx.doi.org/10.1016/0040-4020(68)88159-1] [PMID: 5732891]
[91]
Vollner L, Bieniek D, Korte F. Review of analytical methods for identification and quantification of Cannabis products. Regul Toxicol Pharmacol 1986; 6(4): 348-58.
[http://dx.doi.org/10.1016/0273-2300(86)90003-6] [PMID: 3027768]
[92]
Fischedick JT, Glas R, Hazekamp A, Verpoorte R. A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L. Phytochem Anal 2009; 20(5): 421-6.
[http://dx.doi.org/10.1002/pca.1143] [PMID: 19609880]
[93]
Galand N, Ernouf D, Montigny F, Dollet J, Pothier J. Separation and identification of cannabis components by different planar chromatography techniques (TLC, AMD, OPLC). J Chromatogr Sci 2004; 42(3): 130-4.
[http://dx.doi.org/10.1093/chromsci/42.3.130] [PMID: 15023248]
[94]
Hazekamp A, Choi YH, Verpoorte R. Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chem Pharm Bull (Tokyo) 2004; 52(6): 718-21.
[http://dx.doi.org/10.1248/cpb.52.718] [PMID: 15187394]
[95]
Choi YH, Hazekamp A, Peltenburg-Looman AMG, et al. NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochem Anal 2004; 15(6): 345-54.
[http://dx.doi.org/10.1002/pca.787] [PMID: 15595449]
[96]
Choi YH, Kim HK, Hazekamp A, Erkelens C, Lefeber AWM, Verpoorte R. Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. J Nat Prod 2004; 67(6): 953-7.
[http://dx.doi.org/10.1021/np049919c] [PMID: 15217272]
[97]
Zaripov EA, Lee T, Dou Y, Harris CS, Egorov A, Berezovski MV. Single-run separation and quantification of 14 cannabinoids using capillary electrophoresis. Separations 2021; 8(3): 30.
[http://dx.doi.org/10.3390/separations8030030]
[98]
Calzolari D, Magagnini G, Lucini L, Grassi G, Appendino GB, Amaducci S. High added-value compounds from Cannabis threshing resi-dues. Ind Crops Prod 2017; 108: 558-63.
[http://dx.doi.org/10.1016/j.indcrop.2017.06.063]
[99]
Dussy FE, Hamberg C, Luginbühl M, Schwerzmann T, Briellmann TA. Isolation of Δ9-THCA-A from hemp and analytical aspects concerning the determination of Δ9-THC in cannabis products. Forensic Sci Int 2005; 149(1): 3-10.
[http://dx.doi.org/10.1016/j.forsciint.2004.05.015] [PMID: 15734104]
[100]
Muntendam R, Happyana N, Erkelens T, Bruining F, Kayser O. Time dependent metabolomics and transcriptional analysis of cannabinoid biosynthesis in Cannabis sativa var. bedrobinol and bediol grown under standardized condition and with genetic homogeneity. Online Int J Med Plants Res 2012; 1(2): 31-40.
[101]
Mariotti KC, Marcelo MCA, Ortiz RS, et al. Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatography-mass spectrometry and chemometric analysis. Sci Justice 2016; 56(1): 35-41.
[http://dx.doi.org/10.1016/j.scijus.2015.09.002] [PMID: 26746824]
[102]
Broséus J, Vallat M, Esseiva P. Multi-class differentiation of cannabis seedlings in a forensic context. Chemom Intell Lab Syst 2011; 107(2): 343-50.
[http://dx.doi.org/10.1016/j.chemolab.2011.05.004]
[103]
Fiorini D, Molle A, Nabissi M, Santini G, Benelli G, Maggi F. Valorizing industrial hemp (Cannabis sativa L.) by-products: Cannabidiol enrichment in the inflorescence essential oil optimizing sample pre-treatment prior to distillation. Ind Crops Prod 2019; 128: 581-9.
[http://dx.doi.org/10.1016/j.indcrop.2018.10.045]
[104]
Hazekamp A, Fischedick JT. Cannabis - from cultivar to chemovar. Drug Test Anal 2012; 4(7-8): 660-7.
[http://dx.doi.org/10.1002/dta.407] [PMID: 22362625]
[105]
Omar J, Olivares M, Amigo JM, Etxebarria N. Resolution of coeluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares. Talanta 2014; 121: 273-80.
[http://dx.doi.org/10.1016/j.talanta.2013.12.044] [PMID: 24607138]
[106]
Bruci Z, Papoutsis I, Athanaselis S, et al. First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. Forensic Sci Int 2012; 222(1-3): 40-6.
[http://dx.doi.org/10.1016/j.forsciint.2012.04.032] [PMID: 22608266]
[107]
Braithwaite I, Bhagavan C, Doppen M, Kung S, Oldfield K, Newton-Howes G. Medicinal applications of cannabis/cannabinoids. Curr Opin Psychol 2021; 38: 1-10.
[http://dx.doi.org/10.1016/j.copsyc.2020.06.002] [PMID: 32652488]
[108]
Harris HM, Rousseau MA, Wanas AS, et al. Role of cannabinoids and terpenes in cannabis-mediated analgesia in rats. Cannabis Cannabinoid Res 2019; 4(3): 177-82.
[http://dx.doi.org/10.1089/can.2018.0054] [PMID: 31579834]
[109]
Moreau M, Ibeh U, Decosmo K, et al. Flavonoid derivative of Cannabis demonstrates therapeutic potential in preclinical models of metastatic pancreatic cancer. Front Oncol 2019; 9: 660.
[http://dx.doi.org/10.3389/fonc.2019.00660] [PMID: 31396485]
[110]
Downer EJ. Anti-inflammatory potential of terpenes present in Cannabis sativa L. ACS Chem Neurosci 2020; 11(5): 659-62.
[http://dx.doi.org/10.1021/acschemneuro.0c00075] [PMID: 32091871]
[111]
Bautista JL, Yu S, Tian L. Flavonoids in Cannabis sativa: Biosynthesis, bioactivities, and biotechnology. ACS Omega 2021; 6(8): 5119-23.
[http://dx.doi.org/10.1021/acsomega.1c00318] [PMID: 33681553]
[112]
Antezana PE, Municoy S, Pérez CJ, Desimone MF. Collagen hydrogels loaded with silver nanoparticles and Cannabis sativa oil. Antibiotics 2021; 10(11): 1420.
[http://dx.doi.org/10.3390/antibiotics10111420] [PMID: 34827358]
[113]
Klahn P. Cannabinoids-promising antimicrobial drugs or intoxicants with benefits? Antibiotics 2020; 9(6): 297.
[http://dx.doi.org/10.3390/antibiotics9060297] [PMID: 32498408]

Rights & Permissions Print Cite
Article Metrics
50
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy